SCHEMBL2928012

SCHEMBL2928012

C=CC(C)(C(=O)O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TSHR P16473 1/20 0.48
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP2C19 P33261 3/20 0.44
HIF1A Q16665 1/20 0.44
CYP1A2 P05177 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
HTT P42858 1/20 0.42
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20557179 1.00 ALDH1A1 (0.48) ALDH1A1TSHRMAPTKMT2ACYP2C19
SCHEMBL20556967 0.84 TSHR (0.41) ALDH1A1TSHRMAPTKMT2AHDAC1
SCHEMBL20556968 0.84 TSHR (0.41) ALDH1A1TSHRMAPTKMT2AHDAC1
SCHEMBL20556753 0.82 SMN1; SMN2 (0.42) MAPTKMT2ACYP2C19HDAC3HDAC1
SCHEMBL20556899 0.82 MEN1 (0.45) TSHRMAPTKMT2ACYP2C19HIF1A
SCHEMBL20556898 0.82 MEN1 (0.45) TSHRMAPTKMT2ACYP2C19HIF1A
SCHEMBL20557141 0.82 NR4A1 (0.46) ALDH1A1CYP1A2HDAC3HDAC1HDAC2
SCHEMBL20557140 0.82 NR4A1 (0.46) ALDH1A1CYP1A2HDAC3HDAC1HDAC2
SCHEMBL20556754 0.82 SMN1; SMN2 (0.42) MAPTKMT2ACYP2C19HDAC3HDAC1
SCHEMBL20556745 0.82 KIF11 (0.40) ALDH1A1TSHRKMT2ACYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770780-B1 QUATERNIZATION OF T-BUTYL BROMOACETATE WITH TRI(N-BUTYL)PHOSPHINE TO FORM PHOSPHONIUM SALT; REACTING WITH BASE TO FORM PHOSPHORUS YLIDE; FORMING 2,4,6-TRIS(3', 5'-DI-T-BUTYL-4'-HYDROXYBENZYL)METHYL-STYRENE; HYDROLYSIS JSR CORPORATION (JP) 2004-08-03 US claimed
EP-1231205-A1 VINYLPHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PRODUCTION OF THE DERIVATIVES, POLYMERS THEREOF AND RADIOSENSITIVE RESIN COMPOSITIONS JSR Corporation (JP) 2002-08-14 EP claimed
CN-105585677-B Method for producing electrophoretic particle, electrophoretic dispersion liquid, electrophoretic sheet, electrophoretic device, and electronic apparatus 伊英克公司 2022-03-11 CN disclosed
US-10969647-B2 Electrophoretic particle, method of manufacturing electrophoretic particle, electrophoresis dispersion liquid, electrophoresis sheet, electrophoresis device, and electronic apparatus E INK CORPORATION (US) 2021-04-06 US disclosed
CN-105974708-B Electrophoretic particle, method for producing electrophoretic particle, electrophoretic dispersion liquid, electrophoretic sheet, electrophoretic device, and electronic apparatus 伊英克公司 2021-03-23 CN disclosed
EP-3704113-A1 BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2020-09-09 EP disclosed
US-10336678-B2 Compositions and methods for preparing β,γ-unsaturated acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-07-02 US disclosed
US-20180327343-A1 COMPOSITIONS AND METHODS FOR PREPARING BETA,GAMMA-UNSATURATED ACIDS CALIFORNIA INSTITUTE OF TECHNOLOGY 2018-11-15 US disclosed
CN-105974708-A Electrophoretic particle, method of manufacturing electrophoretic particle, electrophoresis dispersion liquid, electrophoresis sheet, electrophoresis device, and electronic apparatus 精工爱普生株式会社 2016-09-28 CN disclosed
US-20160266462-A1 ELECTROPHORETIC PARTICLE, METHOD OF MANUFACTURING ELECTROPHORETIC PARTICLE, ELECTROPHORESIS DISPERSION LIQUID, ELECTROPHORESIS SHEET, ELECTROPHORESIS DEVICE, AND ELECTRONIC APPARATUS E INK CORPORATION 2016-09-15 US disclosed
CN-105585677-A Method of manufacturing electrophoretic particle, electrophoretic particle, electrophoretic dispersion, electrophoretic sheet, electrophoretic device, and electronic apparatus SEIKO EPSON CORP 2016-05-18 CN disclosed
US-20050267252-A1 Electrophoretic particles and production process thereof CANON KABUSHIKI KAISHA (JP) 2005-12-01 US disclosed
US-6770780-B1 QUATERNIZATION OF T-BUTYL BROMOACETATE WITH TRI(N-BUTYL)PHOSPHINE TO FORM PHOSPHONIUM SALT; REACTING WITH BASE TO FORM PHOSPHORUS YLIDE; FORMING 2,4,6-TRIS(3', 5'-DI-T-BUTYL-4'-HYDROXYBENZYL)METHYL-STYRENE; HYDROLYSIS JSR CORPORATION (JP) 2004-08-03 US disclosed
US-6770780-B1 QUATERNIZATION OF T-BUTYL BROMOACETATE WITH TRI(N-BUTYL)PHOSPHINE TO FORM PHOSPHONIUM SALT; REACTING WITH BASE TO FORM PHOSPHORUS YLIDE; FORMING 2,4,6-TRIS(3', 5'-DI-T-BUTYL-4'-HYDROXYBENZYL)METHYL-STYRENE; HYDROLYSIS JSR CORPORATION (JP) 2004-08-03 US disclosed
US-6770780-B1 QUATERNIZATION OF T-BUTYL BROMOACETATE WITH TRI(N-BUTYL)PHOSPHINE TO FORM PHOSPHONIUM SALT; REACTING WITH BASE TO FORM PHOSPHORUS YLIDE; FORMING 2,4,6-TRIS(3', 5'-DI-T-BUTYL-4'-HYDROXYBENZYL)METHYL-STYRENE; HYDROLYSIS JSR CORPORATION (JP) 2004-08-03 US disclosed
EP-1231205-A4 VINYLPHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PRODUCTION OF THE DERIVATIVES, POLYMERS THEREOF AND RADIOSENSITIVE RESIN COMPOSITIONS JSR CORP (JP) 2004-05-26 EP disclosed
EP-1231205-A1 VINYLPHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PRODUCTION OF THE DERIVATIVES, POLYMERS THEREOF AND RADIOSENSITIVE RESIN COMPOSITIONS JSR Corporation (JP) 2002-08-14 EP disclosed
EP-1231205-A1 VINYLPHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PRODUCTION OF THE DERIVATIVES, POLYMERS THEREOF AND RADIOSENSITIVE RESIN COMPOSITIONS JSR Corporation (JP) 2002-08-14 EP disclosed
JP-2001316333-A VINYLPHENYLPROPIONIC ACID DERIVATIVE AND METHOD FOR PRODUCING THE SAME JSR CORP 2001-11-13 JP disclosed
WO-2001036370-A1 VINYLPHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PRODUCTION OF THE DERIVATIVES, POLYMERS THEREOF AND RADIOSENSITIVE RESIN COMPOSITIONS JSR CORPORATION (JP) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336678-B2 Compositions and methods for preparing β,γ-unsaturated acids ELOVL5, FASN, ACSL5 ALDH1A1 239/4885TSHR 4005/4885MAPT 4276/4885
US-20180327343-A1 COMPOSITIONS AND METHODS FOR PREPARING BETA,GAMMA-UNSATURATED ACIDS ELOVL5, FASN, ACSL5 ALDH1A1 249/4885TSHR 4005/4885MAPT 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.